SRPT
NASDAQ
US
Sarepta Therapeutics, Inc. - Common Stock
$23,23
▲ +$1,10
(+4,97%)
Vol. 3.1M
5
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$2.3B
ROE
-20,3%
Margine
-11,3%
D/E
78,41
Beta
0,39
52W
$10–$130
Consenso Wall Street
33 analisti · Apr 20267
Acquisto forte
6
Compra
15
Mantieni
4
Vendi
1
Vendita forte
39,4%
Rating Compra
Grafico dei Prezzi
Titoli simili
VCYT
Veracyte Inc
P/E 110,3
$3.3B
BEAM
Beam Therapeutics Inc
$2.8B
IRON
Disc Medicine Inc
$3.0B
KOD
Kodiak Sciences Inc
$1.7B
IMNM
Immunome Inc
$2.4B
BCRX
BioCryst Pharmaceuticals Inc
$1.6B
GRAL
Grail Inc
$3.3B
RLAY
Relay Therapeutics Inc
$1.5B
MLYS
Mineralys Therapeutics Inc
$2.9B
SNDX
Syndax Pharmaceuticals Inc
$1.8B
Utili
Tasso di battuta: 50,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $-1,26 | $-3,93 | $-2,67 |
| Set 2025 | $-0,83 | $-0,01 | +$0,82 |
| Giu 2025 | $0,77 | $1,89 | +$1,12 |
| Mar 2025 | $-0,97 | $-4,60 | $-3,63 |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -4.4% | -4.4% | -4.4% | -4.4% | -20.3% | -20.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | 32.2% | -2.3% | -2.3% | -2.3% | -11.2% | -11.2% |
| Gross Margin | 75.0% | 79.3% | 79.3% | 79.3% | 76.2% | 76.2% |
| D/E Ratio | 83.95 | 83.95 | 83.95 | 83.95 | 78.41 | 78.41 |
| Current Ratio | 2.89 | 2.89 | 2.89 | 2.89 | 2.95 | 2.95 |
Rapporti chiave
ROA (TTM)
-7,4%
P/S (TTM)
0,93
P/B
7,6
EPS (TTM)
$-3,35
CF/Share
$-7,32
Crescita ricavi 3A
+39,4%
52W High
$129,84
52W Low
$10,42
$10,42
Intervallo 52 settimane
$129,84
Як SRPT виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка SRPT vs аналоги Biotechnology
P/E
—
▼
0%
sotto
peer
(18,8)
vs Peer
vs Settore
Sottovalutato
P/S
0,9
▼
93%
sotto
peer
(12,9)
vs Peer
vs Settore
Sottovalutato
P/B
7,6
▲
209%
sopra
peer
(2,5)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,0%)
vs Peer
vs Settore
Rendimento basso
Прибутковість SRPT vs аналоги Biotechnology
ROE
-20,3%
▲
70%
sopra
peer
(-67,3%)
vs Peer
vs Settore
Top livello
Net margin
-11,3%
▲
96%
sopra
peer
(-286,8%)
vs Peer
vs Settore
Sotto media
Валова маржа
76,3%
▼
3%
sotto
peer
(78,6%)
vs Peer
vs Settore
Debole
ROA
-7,4%
▲
84%
sopra
peer
(-46,7%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя SRPT vs аналоги Biotechnology
D/E ratio
78,4
▼
0%
sotto
peer
(0,0)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
3,0
▼
33%
sotto
peer
(4,4)
vs Peer
vs Settore
Liquidità bassa
Beta
0,4
▼
60%
sotto
peer
(1,0)
vs Peer
vs Settore
Più volatile
Радар фундаменталів SRPT
SRPT
Mediana peer
Industria
SRPT прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio